We’ve rebranded some of our products, learn more ›

CODEX® is now PhenoCycler,
Phenoptics™ is now Phenolmager.

Transforming biomarker development for cancer immunotherapy: Introducing the PhenoCode Signature approach

Webinar | Mar 27, 2023 | 8AM PT | 11AM ET | 5PM CET

As cancer treatment evolves with the advent of new immunotherapies, it is crucial to accurately identify which patients will respond to these treatments. The tumor microenvironment (TME) has been shown to be a key factor in determining therapeutic responses across various cancer types. In this webinar, Dr Ning Ma, Sr. Applications Scientist at Akoya Biosciences, will discuss the latest tools for analyzing the TME and simplifying the process of developing predictive biomarkers. The PhenoCode™ Signature panels from Akoya Biosciences provides the right balance of content, flexibility, speed, and scalability needed to advance biomarker development. Discover how the PhenoCode Signature approach is revolutionizing the way biomarkers are developed for immunotherapy response.

Key learning objectives

  • Understand the predictive limits of current biomarkers for immunotherapy and the power of spatial signatures
  • Discover the power of PhenoCode Signature panels in accelerating spatial phenotyping and spatial signature development
  • Learn how to use PhenoCode Signature in a discovery-to-translational workflow to identify spatial signatures




Ning Ma

Dr. Ning Ma

Senior Application Scientist
Akoya Biosciences

Dr. Ning Ma received her doctorate in Bioengineering and Biomedical Engineering from the University of California, Irvine where she studied embryo health and CTC metabolism using fluorescence lifetime imaging microscopy. Following her postdoctoral studies at Stanford University, she joined the applications team at Akoya Biosciences where she leads application projects spanning the discovery-to-translational workflows.